Thursday, March 18, 2021 1:00:55 AM
https://healthyextractsinc.com/
Key 2020 Activities:
Gross revenue was up 71% in 2020, even with some continued negative effects of COVID.
Healthy Extracts Inc. (HYEX) name change from Grey Cloak Tech to better align its companies.
Full reporting and upgraded to the OTCQB in October 2020.
Independent report conducted by Trickle Research projecting positive stock growth.
Company eliminated all convertible debt.
Net shareholder equity increase of $3.7 million.
Acquired Ultimate Brain Nutrients for its breakthrough brain products, including six patents (2 issued, 4 pending) and its proprietary formulations.
Introduction of the revolutionary Clinical Immune, the only immune product formulated and clinically proven focusing on heart and respiratory immune health.
Key clinical studies on its proprietary unique Fuel4Thought Brain Booster product, with sales beginning in Q2.
Pilot study completed on the Company’s Fuel4Thought Migraine formulation with great results; study was published in the renowned World Journal of Advanced Research and Reviews.
Release of HerHeart, the only cardiovascular product designed just for women; positive clinical trial results published in Annals of Women's Health. Cardiovascular disease is and will likely remain the No. 1 cause of death in the U.S. for women and men.
Recent HYEX News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:22:30 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 10/24/2023 06:25:27 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 10/06/2023 06:09:39 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/14/2023 05:22:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 06:30:40 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 09/05/2023 08:24:27 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 08/24/2023 08:12:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 09:09:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2023 05:30:59 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM